Zemplar
Zemplar is an originator product from AbbVie AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 67.80 to CHF 254.50 depending on the pack; the patient co-payment is 10 per cent plus the deductible.
Core data
- Authorisation holder
- AbbVie AG
- ATC code
- H05BX02
- IT group
- 07.05.20 Calcitonine
- Active substances
- Paricalcitolum
- Preparation type
- Originator product
- On the SL since
- 01/09/2008
- Last price change
- 01/12/2023
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Kaps 1 mcg | 28 Stk | CHF 109.46 | CHF 135.45 | 01/09/2008 | B | 7680579890047 |
| Kaps 2 mcg | 28 Stk | CHF 218.90 | CHF 254.50 | 01/09/2008 | B | 7680579890085 |
| Inj Lös 2 mcg/ml | 5 Durchstf 1 ml | CHF 47.23 | CHF 67.80 | 01/03/2016 | B | 7680563120020 |
| Inj Lös 5 mcg/ml | 5 Durchstf 1 ml | CHF 97.97 | CHF 122.95 | 01/03/2016 | B | 7680563120044 |
Limitation
This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.
The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.
Die Diagnosestellung muss durch einen in der Nephrologie ausgewiesenen Arzt erfolgen.
Zur Behandlung des sekundären Hyperparathyreoidismus bei Patienten mit terminaler Niereninsuffizienz (CKD Stufe 5) und chronischer Hämodialyse oder Peritonealdialyse.
Die Verschreibung muss durch einen in der Nephrologie ausgewiesenen Arzt erfolgen.
Die Verschreibung muss durch einen in der Nephrologie ausgewiesenen Arzt erfolgen.
FAQ
Is Zemplar covered by Swiss health insurance?
Yes, but only under conditions. Zemplar is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.
What does Zemplar cost in Switzerland?
The public price is the maximum price set by the FOPH and for Zemplar ranges from CHF 67.80 to CHF 254.50 per pack. The ex-factory price ranges from CHF 47.23 to CHF 218.90. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages